IP Library Granted Patent US 7,846,895
Granted Patent B2
US 7,846,895 · App. 11/851,372 · Granted Dec 7, 2010

Selectively targeted antimicrobial peptides and the use thereof

Assignees: The Regents of the University of California; C3 Jian, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,895
App. No.
11/851,372
Granted
Dec 7, 2010
Kind
B2
Abstract

The present invention relates to targeting peptides capable of specifically binding to microbial organisms (e.g., P. aeruginosa or S. mutans ), antimicrobial peptides having antimicrobial activities, and specifically/selectively targeted antimicrobial peptides (STAMPs). In addition, the present invention provides methods of selectively killing or inhibiting microbial organisms by using the peptides or compositions provided by the present invention.

Claims (13)

1. A composition comprising a targeting peptide that binds Streptococcus mutans , the amino acid sequence of said peptide consisting of the sequence TFFRLFNRSFTQALGK (SEQ ID NO:2) attached to a detectable agent or to an antimicrobial peptide.

2. The composition of claim 1 , wherein said targeting peptide is attached to an antimicrobial peptide.

3. The composition of claim 2 , wherein the amino acid sequence of said antimicrobial peptide consists of the sequence KNLRIIRKGIHIIKKY (SEQ ID NO:3).

4. The composition according to any one of claims 2 and 3 , wherein the targeting peptide is attached to the antimicrobial peptide by a linker peptide.

5. The composition of claim 4 , wherein the amino acid sequence of the linker peptide is GGG (SEQ ID NO:17).

6. The composition of claim 2 , wherein the targeting peptide attached to the antimicrobial peptide consists of the amino acid sequence TFFRLFNRSFTQALGKGGGKNLRIIRKGIHIIKKY (SEQ ID NO:4), wherein the carboxyl terminus of SEQ ID NO:4 is amidated.

7. The composition of claim 1 , wherein said targeting peptide is attached to a detectable agent.

8. The composition of claim 7 , wherein the targeting peptide is conjugated to the detectable agent.

9. The composition of claim 7 , wherein the detectable agent is selected from the group consisting of a radioisotope, a fluorescent agent, and an enzyme-substrate agent.

10. A composition comprising an antimicrobial peptide, the amino acid sequence of said peptide consisting of the sequence KNLRIIRKGIHIIKKY (SEQ ID NO:3).

11. The composition of claim 10 , wherein said antimicrobial peptide is attached to a targeting peptide.

12. The composition of claim 11 , wherein the antimicrobial peptide is linked to one terminus of a linker peptide, wherein the other terminus of the linker peptide is linked to said targeting peptide.

13. The composition of claim 12 wherein the amino acid sequence of said linker peptide consists of the sequence GGG (SEQ ID NO:17).

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2008
From: SHI, WENYUAN; ECKERT, RANDAL H.; YARBROUGH, DANIEL K.; QI, FENGXIA; HE, JIAN; MCHARDY, IAN H.
To: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Reel/Frame 020871/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2008
From: ANDERSON, MAXWELL
To: C3 JIAN, INC.
Reel/Frame 020871/0263 →
Continuity (2)
Provisional Application 6084287100 · Sep 6, 2006
Related Publication 20080170991A1 · Jul 17, 2008